News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Teva Pharmaceutical Industries Limited in Court Over AstraZeneca PLC’s Seroquel Patent
January 24, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Israel's Teva Pharmaceutical Industries (TEVA.O) has launched a High Court action in London to revoke the European patent for Seroquel, an anti-depressant developed by AstraZeneca (AZN.L), the Sunday Times reported.
Twitter
LinkedIn
Facebook
Email
Print
Legal
AstraZeneca
MORE ON THIS TOPIC
Regulatory
Tavneos no longer available for new patients in UK as Amgen awaits FDA hearing
September 2, 2026
·
2 min read
·
Tristan Manalac
Drug pricing
9 midsize drugmakers climb aboard Trump’s MFN train
September 1, 2026
·
2 min read
·
Tristan Manalac
Legal
Biomarin nabs big royalties in achondroplasia patent settlement with Ascendis
August 31, 2026
·
2 min read
·
Annalee Armstrong
Vaccines
Kennedy questions vaccination guidelines following Trump’s order to break up MMR
August 24, 2026
·
2 min read
·
Tristan Manalac